Business

Voyageur Pharmaceuticals Announces Appointment of Ethan Mohan as Executive Vice President

(TheNewswire) Calgary, Alberta, Canada – May 12, 2025 – TheNewswire - ...

articleVoyageur Pharmaceuticals LtdMay 12, 20254/company/voyageur-pharmaceuticals-ltd/news/voyageur-pharmaceuticals-announces-appointment-of-ethan-mohan-as-executive-vice-president
Voyageur Pharmaceuticals Announces Appointment of Ethan Mohan as Executive Vice President

About this update from Voyageur Pharmaceuticals Ltd

[{"type":"text","content":"Voyageur Pharmaceuticals Announces Appointment of Ethan Mohan as Executive Vice President\n\n\n (TheNewswire)\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n Calgary, Alberta, Canada – May 12, 2025 –\n \n\n TheNewswire -\n \n\n Voyageur\nPharmaceuticals Ltd. (\n \n\n TSX.V:VM\n \n\n ) (\n \n\n OTC Pink:VYYRF\n \n\n )\n(\"\n \n\n Voyageur\n \n\n \" or the \"\n \n\n Company\n \n\n \") a radiology contrast media\ncompany focused on vertical integration and secure supply chains,\n \n\n is pleased to announce the appointment of Ethan\nMohan as Executive Vice President of Voyageur, subject to regulatory\napproval. Mr. Mohan's appointment is a promotion from his previous\nposition of Sales Manager of Voyageur and marks another strategic\nadvancement in the Company’s leadership team as it continues to move\ntowards the establishment of a sales presence.\n \n\n\n\n Mr. Mohan has been a pivotal force behind forging\nVoyageur’s sales strategies and strategic partnerships that have set\nthe stage for the Company’s market presence. Since joining Voyageur,\nMr. Mohan has consistently demonstrated exceptional leadership,\nstrategic foresight, and operational expertise, along with an\nunwavering commitment to advancing the Company’s vision of becoming\na global leader in the radiographic contrast agent market.\n \n\n\n\n As Executive Vice President, Mr. Mohan will take on an\nexpanded role overseeing corporate strategy, business development, and\ninternational market expansion initiatives, while continuing to\nchampion Voyageur’s mission of delivering high-quality, sustainable\nbarium and iodine-based products to the global healthcare\nmarket.\n \n\n\n\n “Ethan’s promotion marks an important milestone for\nVoyageur as we enter a transformative phase in our growth,” said\nBrent Willis, CEO of Voyageur.\n \n\n “Ethan brings a\nrare combination of scientific expertise and entrepreneurial acumen\nthat we expect will directly lead to the development of commercial\nsuccess for Voyageur. His leadership has positioned the Company to be\nin a position to capitalize on emerging global opportunities. As we\nmove forward with the development of Frances Creek, navigate FDA\nregulatory pathways, and scale our international footprint, Ethan’s\nstrategic insigh...

More updates from Voyageur Pharmaceuticals Ltd